DEF 14A
DEFINITIVE PROXY STATEMENT
- Company
- LEXICON PHARMACEUTICALS, INC.
- Filed
- June 5, 2009
- Period of Report
- June 5, 2009
- Accession Number
- 0001062822-09-000075
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →